Tag: Spark Therapeutics. US FDA
US FDA approves Spark’s gene therapy Luxturna for rare form of vision loss
Luxturna FDA approval : Luxturna (voretigene neparvovec), a gene therapy from Spark Therapeutics has secured the approval from the US Food and Drug Administration (FDA) ... Read More